Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 24, 2008
A phase I study of the safety and pharmacokinetics of trabectedin in combination with pegylated liposomal doxorubicin in patients with advanced malignanciesM von Mehren, R J Schilder, J D Cheng, et al.
British Journal of Pharmacology|September 1, 1994
BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174K E Dickinson, R B Cohen, S Skwish, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 30, 2017
Needle tract seeding following core biopsies in retroperitoneal sarcomaW J Van Houdt, A M Schrijver, R B Cohen-Hallaleh, et al.
The Journal of Infectious Diseases|October 1, 1993
A pilot study of sequential therapy with zidovudine plus acyclovir, dideoxyinosine, and dideoxycytidine in patients with severe human immunodeficiency virus infectionB Y Nguyen, L E Shay, K M Wyvill, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2006
A phase I safety, pharmacological and biological study of the farnesyl protein transferase inhibitor, tipifarnib and capecitabine in advanced solid tumorsL Gore, S N Holden, R B Cohen, et al.
Clinical Sarcoma Research|August 11, 2017
Radiation induced angiosarcoma of the breast: outcomes from a retrospective case seriesR B Cohen-Hallaleh, H G Smith, R C Smith, et al.
British Journal of Cancer|September 22, 2012
Phase I study of axitinib combined with paclitaxel, docetaxel or capecitabine in patients with advanced solid tumoursL P Martin, M F Kozloff, R S Herbst, et al.
British Journal of Cancer|May 18, 2006
Phase 1 trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH(2)), a beta integrin antagonist, in patients with solid tumoursM E Cianfrocca, K A Kimmel, J Gallo, et al.
AIDS (London, England)|November 5, 1999
HIV-specific immunity following immunization with HIV synthetic envelope peptides in asymptomatic HIV-infected patientsL A Pinto, J A Berzofsky, K R Fowke, et al.
International Journal of Clinical Pharmacology and Therapeutics|March 14, 2009
Bioequivalence study of a new oral topotecan formulation, relative to the current topotecan formulation, in patients with advanced solid tumorsR L Oostendorp, J Loftiss, S Goel, et al.
Pageof 8